Allergan Swoops in and Bags Troubled Repros Therapeutics Post author:Sam Post published:December 11, 2017 Post category:BioPharma The deal is expected to close in the first quarter of 2018. Source: BioSpace You Might Also Like Veracyte Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis May 18, 2017 Insiders Just Bought $234 Million Worth of These Pharma Stocks June 21, 2017 Cutera Strengthens Leadership Team With Two Key Executive Appointments August 20, 2017
Veracyte Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis May 18, 2017
